Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Multicenter Phase I Study of MRX34, MicroRNA miR-RX34 Liposomal Injection

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01829971
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:36:25.842641+00:00
Published At
2016-09-27T00:00:00+00:00
Record Updated At
2016-09-27
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Primary Liver Cancer", "SCLC", "Lymphoma", "Melanoma", "Multiple Myeloma", "Renal Cell Carcinoma", "NSCLC"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2016-09-27"
protocolSection.identificationModule.nctId
"NCT01829971"
protocolSection.identificationModule.officialTitle
"A Multicenter Phase I Study of MRX34, MicroRNA miR-RX34 Liposomal Injection"
protocolSection.statusModule.overallStatus
"TERMINATED"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Primary Liver Cancer (protocolSection.conditionsModule.conditions)
  • SCLC (protocolSection.conditionsModule.conditions)
  • Lymphoma (protocolSection.conditionsModule.conditions)
  • Melanoma (protocolSection.conditionsModule.conditions)
  • Multiple Myeloma (protocolSection.conditionsModule.conditions)
  • Renal Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • NSCLC (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.